Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells

Cited by (344)

Items 201–300 of 344

1. In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors
   Qi Liu, Peixin Amy Chen, Esha Urs, Shimin Zhang, Maya M. Arce, Charlotte H. Wang, Zhongmei Li, Jin Seo, Nupura Kale, Taylor N. LaFlam et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
2. CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy
   Yuhui Ma, Junxin Chen, Yuan Du, Zhi‐Hao Cao, Weizhi Ji, Yuyu Niu, Zebin Yang · 2025 · Open Research (University of Surrey)
3. Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma
   Margaret A. Potts, Shin-ya Mizutani, Yexuan Deng, Srimayee Vaidyanathan, Keziah E. Ting, Göknur Giner, Shruti Sridhar, Girija Shenoy, Yang Liao, Sarah T. Diepstraten et al. · 2025 · Nature Communications
4. Unraveling the critical role of SUMOylation in the governing of tumor immunity
   Xiangfei Liu, Wei Ding, Lu Jiang, Qianming Chen, Xiaobo Luo · 2025 · Frontiers in Immunology
5. Protein palmitoylation and sphingolipid metabolism control regulated exocytosis in cytotoxic lymphocytes
   Artem Kalinichenko, Jakob Huemer, Theresa Humer, Matthias Haimel, Michael Svatoň, Nicolas Socquet-Juglard, Giovanna Perinetti Casoni, Celine Prakash, Maximilian von der Linde, Júlia Pázmándi et al. · 2025 · Science Immunology
6. Developing pioneering pharmacological strategies with CRISPR/Cas9 library screening to overcome cancer drug resistance
   Yu He, Huan Li, Xueming Ju, Bo Gong · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
7. EBAG9 silencing exerts an immune checkpoint function without aggravating adverse effects
   Anthea Wirges, Mario Bunse, Jara J. Joedicke, Eric Blanc, Venugopal Gudipati, Michael W. Moles, Hiroshi Shiku, Dieter Beule, Johannes B. Huppa, Uta E. Höpken et al. · 2022 · Molecular Therapy
8. Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors
   Jiakai Hou, Shaoheng Liang, Chunyu Xu, Yanjun Wei, Yunfei Wang, Yukun Tan, Nidhi Sahni, Daniel James McGrail, Chantale Bernatchez, Michael A. Davies et al. · 2022 · NAR Cancer
9. Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
   Mengxin Wang, Stephen Vulcano, Changlu Xu, Renjian Xie, Weijie Peng, Jie Wang, Qiaojun Liu, Lee Jia, Zhi Li, Yumei Li · 2023 · Journal of Pharmaceutical Analysis
10. Genetic Screening for Novel Regulators of Immune Checkpoint Molecules
    Ramon Arens, Ferenc A. Scheeren · 2020 · Trends in Immunology
11. Improving Cancer Immunotherapy with CRISPR‐Based Technology
    Zexu Li, Fei Teng · 2020 · Advanced Biosystems
12. Commentary: Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer
    Rafael Rosell, Martyna Filipska, Imane CHAIB-OUKADOUR, David Lligé, Fernando Laguía · 2020 · Frontiers in Oncology
13. Cas12a/Cpf1 knock-in mice enable efficient multiplexed immune cell engineering
    Matthew B. Dong, Kaiyuan Tang, Xiaoyu Zhou, Johanna Shen, Krista Chen, Hyunu R. Kim, Jerry Zhou, Hanbing Cao, Erica Vandenbulcke, Yueqi Zhang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
14. A unified genetic perturbation language for human cellular programming
    Austin Hartman, Oliver Takacsi-Nagy, Courtney Kernick, Nicole E. Theberath, Johnathan Lu, Lujing Wu, Michelle Mantilla, Siddhesh Mittra, Alison K. McClellan, Nicole Johnson et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
15. Genome editing or small molecule inhibition of KMT5A in CAR-T cells enhances antitumor immunity
    Xiaoling Tian, Guolong Liu, Qiudao Wang, Na Zhang, Yanting Shen, Bing Du, Yuxuan Wu · 2025 · Journal for ImmunoTherapy of Cancer
16. An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model
    Mattia Fumagalli, Dongjie An, Luca Simula, Camille Combe, Lisa Aziez, Yannick Simoni, Marie‐Clotilde Alves‐Guerra, Andrea Valentini, Maude Marchais, Anaïs Vermare et al. · 2026 · Molecular Therapy
17. Dissecting host–microbe interactions with modern functional genomics
    Baylee J. Russell, Manasvi Verma, Nolan K. Maier, Marco Jost · 2024 · Current Opinion in Microbiology
18. Profile of DHX37 gene defects in human genetic diseases: 46,XY disorders of sex development
    Huifang Peng, Wenyuan Peng, Jiali Chen, Keyan Hu, Yingyu Zhang, Yujin Ma, Hongwei� Jiang · 2025 · Frontiers in Endocrinology
19. Rank aggregation of independent genetic screen results highlights new strategies for adoptive cellular transfer therapy of cancer
    Vianca V. Vianzon, Rylee Hanson, I. D. Garg, Gwenyth J. Joseph, Laura M. Rogers · 2023 · Frontiers in Immunology
20. Identification of cuproptosis-related molecular classification and characteristic genes in ulcerative colitis
    Xinyu Bai, Fengrui Zhang, Chan Zhou, Jingxian Yan, Hao Liang, Rui Zhu, Min Gong, Huixian Song, Junkun Niu, Yinglei Miao · 2024 · Heliyon
21. Finding a needle in a haystack: functional screening for novel targets in cancer immunology and immunotherapies
    Yi Du, Yang Yang, Bohao Zheng, Qian Zhang, Shengtao Zhou, Linjie Zhao · 2025 · Oncogene
22. High-throughput CRISPR approaches: New solutions for challenging problems
    Gargi Bindal, Chitra Seetharam Misra, Mandeep Kumar Singh, Shyam Sunder Rangu, Neha Pandey, Devashish Rath · 2025 · TrAC Trends in Analytical Chemistry
23. Protein engineering: a driving force toward synthetic immunology
    J.R. Cox, John Blazeck · 2021 · Trends in biotechnology
24. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens
    Soorin Yim, Woochang Hwang, Namshik Han, Doheon Lee · 2022 · Frontiers in Immunology
25. Genome-Wide Screening Approaches for Biochemical Reactions Independent of Cell Growth
    Yuki Noguchi, Risa Matsui, Jaeyeon Suh, Yu Dou, Jun Suzuki · 2024 · Annual Review of Genomics and Human Genetics
26. Bourgeoning Cancer Targets
    Priyanka Kriplani · 2022 · Recent Patents on Anti-Cancer Drug Discovery
27. Novel mosaic mice with diverse applications
    Yuxin Chen, Shaoshuai Mao, Bo Liu, Zhengyu Jing, Ying Zang, Jing Xia, Jianlong Sun, Tian H. Chi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
28. Base editing screens map mutations affecting IFNγ signalling in cancer
    Matthew A. Coelho, Emre Karakoç, Shriram G. Bhosle, Emanuel Gonçalves, Thomas Burgold, Sarah Cooper, Chiara Maria Cattaneo, Vivien Veninga, Sarah Consonni, Cansu Dinçer et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
29. Optimized CRISPR guide RNA library cloning reduces skew and enables more compact genetic screens
    Seok‐Jin Heo, Lauren D. Enriquez, Scot Federman, Amy Y. Chang, Rachel Mace, Kaivalya Shevade, Phuong Nguyen, Adam J. Litterman, Shawn Shafer, Laralynne Przybyla et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
30. Testing the plasticity-first theory of tumor evolution with spatiotemporal lineage tracing
    Jinhua Yang, Liangzhen Hou, Xue Wang, Ningxia Zhang, Yifei Bian, Zhaolian Lu, Yanxu Chen, Duo Xie, Yongting Fang, Kun Wang et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
31. In Vivo CRISPR Screening Reveals CHD7 as a Positive Regulator of Short-lived Effector Cells
    Martin W. LaFleur, Jasmin M. D’Andrea, Dillon G. Patterson, Ivy S. L. Streeter, Matthew A. Coxe, Jossef F. Osborn, Lauren E. Milling, Qin Tjokrosurjo, Jacob E. Gillis, Thao H. Nguyen et al. · 2024 · The Journal of Immunology
32. Verteporfin inhibits the cGAS-STING pathway and improves the tumor microenvironment during cisplatin treatment in hepatocellular carcinoma
    Yi Gong, Yajun Xiong, Yuting Gao, Xiaoyong Song, Yanli Gong, Dan Wang, Zhihan Liu, Yanguang Yang, Junlan Lu, Isabelle Xinyue Zou et al. · 2025 · Frontiers in Immunology
33. CRISPR Enabled Precision Oncology: From Gene Editing to Tumor Microenvironment Remodeling
    Kailai Li, Peixin Huang, Yue Qian, Anqi Lin, Jingjun He, Junyi Shen, Li Chen, Kai Miao, Jian Zhang · 2025 · Med Research
34. Multi-omics analysis the effects of Dhx37 deficiency on testis development and nucleolar homeostasis
    Yuqing Jiang, Jiali Chen, Yanshuang Ren, Wenyuan Peng, Wanjun Shen, Yingyu Zhang, Jie Liu, Liujun Fu, Liping Li, Yujin Ma et al. · 2026 · Cell Death Discovery
35. Modulation of Tumor Microenvironment via Antibody Mediated Precision Delivery of CpG to Myeloid Cell
    Yu Xiang, Xiaoyao Hao, Hongyan Li, Zemeng Ma, Zhigang Ma, Liezhou Ji, Zhen Yang, Jialong Wang, Mingjiu Chen, Huricha Baigude · 2026 · Journal of Medicinal Chemistry
36. Emerging CRISPR Approaches for Countering Immune Evasion: Insight from Recent Studies
    Sadam Abubakar, Latifat Abdulsalam, Lamin Fatty, Rimsha Kanwal, Muhammad Naeem, Irshad Ahmad · 2026 · International Journal of Molecular Sciences
37. Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention.
    Jian-Feng Lu, Fengping Ding, Yong-Jie Sun, Yu Zhao, Wenbiao Ma, Huan Zhang, Bo Shi · 2025 · Cellular Signalling
38. High-efficiency of genetic modification using CRISPR/Cpf1 system for engineered CAR-T cell therapy
    Renpeng Ding, Cheng‐Chi Chao, Qianqian Gao · 2022 · Methods in cell biology
39. A metabolomic and proteomic study to elucidate the molecular mechanisms of immunotherapy resistance in patients with oesophageal squamous cell carcinoma
    Lijuan Gao, Yongshun Chen · 2023 · Biomedical Reports
40. Pooled screening with next-generation gene editing tools
    Liqun Zhou, Luojia Yang, Yanzhi Feng, Sidi Chen · 2023 · Current Opinion in Biomedical Engineering
41. CRISPR/Cas9 Technology for Modifying Immune Checkpoint in CAR-T Cell Therapy for Hematopoietic Malignancies
    Forough Shams, Elham Sharif, Hajar Abbasi‐Kenarsari, Nader Hashemi, Masoumeh Sadat Hosseini, Neda Heidari, Effat Noori, Ali Hossein Amini, Maryam Bazrgar, Maryam Rouhani et al. · 2025 · Current Gene Therapy
42. A brief review concerning Chimeric Antigen Receptors T cell therapy
    Ling-Lin Li, Hongling Yuan, Yuqiong Yang, Lin Wang, Renchao Zou · 2020 · Journal of Cancer
43. A model for accurate quantification of CRISPR effects in pooled FACS screens
    Harold Pimentel, Jacob W. Freimer, Maya M. Arce, Christian M. Garrido, Alexander Marson, Jonathan K. Pritchard · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
44. Redirecting cytotoxic lymphocytes to breast cancer tumors via metabolite-sensing receptors
    Young Min Kim, Reece Villarin Akana, Chang Sun, Olivia Laveroni, Livnat Jerby‐Arnon · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
45. Next-generation CRISPR screens enable causal systems immunology
    Hao Shi, Hongbo Chi · 2026 · The Journal of Experimental Medicine
46. Application of extracellular vesicles in the CRISPR-based diagnosis and treatment: possibilities and challenges
    Eunhye Cho, Jehyung Lee, Jiyu Kim, Jaewon Choi, Mikyung Kang, Jayeon Song · 2026 · Journal of Biological Engineering
47. A Comprehensive Review on CRISPR-Based Screening and Its Applications
    Ali Saber Sichani, Mahmoud Hassani, Fatemeh Gila, Negin Shafieipour, Reza Dabbaghipour, Zahra Heidari, Mohsen Sisakht, Mohammad Hassani, Jafar Fallahi · 2026 · Molecular Biotechnology
48. Pediatric Sarcomas: The Next Generation of Molecular Studies
    Petros Giannikopoulos, David M. Parham · 2022 · Cancers
49. Applications of CRISPR screening to lung cancer treatment
    Wanying Shen, Fangli Hu, Lei Pan, Yijun Tang · 2023 · Frontiers in Cell and Developmental Biology
50. Systems Approaches to Unravel T Cell Function and Therapeutic Potential in Autoimmune Disease
    Victor H. Salinas, Olaf Stüve · 2021 · The Journal of Immunology
51. CRISPR as a tool in tumor therapy: A short review
    Jiaqi Tan, Wen Chung Yu · 2020 · Biotechnology and Applied Biochemistry
52. CRISPR-based screens uncover determinants of immunotherapy response in Multiple Myeloma
    Poornima Ramkumar, Anthony B. Abarientos, Ruilin Tian, Meghan Seyler, Jaime T. Leong, Merissa Chen, Priya Choudhry, Torsten Hechler, Nina Shah, Sandy W. Wong et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
53. In vivo CRISPR screening identifies Fli1 as a transcriptional safeguard that restrains effector CD8 T cell differentiation during infection and cancer
    Zeyu Chen, Eri Arai, Omar Khan, Zhen Zhang, Shin Foong Ngiow, Yuan Ming He, Hua Huang, Sasikanth Manne, Zhendong Cao, Amy E. Baxter et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
54. Loss of Rnf31 and Vps4b sensitizes pancreatic cancer to T cell-mediated killing
    Nina Frey, Luigi Tortola, David Egli, Sharan Janjuha, Kim Fabiano Marquart, Tanja Rothgangl, Franziska Ampenberger, Manfred Köpf, Gerald Schwank · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
55. Genome-wide in vivo CRISPR screens identify GATOR1 as a potent tumor suppressor in MYC-driven lymphomagenesis
    Margaret A. Potts, Shin-ya Mizutani, Yexuan Deng, Srimayee Vaidyanathan, Keziah E. Ting, Göknur Giner, Shruti Sridhar, Yang Liao, Sarah T. Diepstraten, A. Kueh et al. · 2022 · bioRxiv
56. Applications of CRISPRi and CRISPRa in Drug Discovery
    Luke A. Gilbert · 2022 · Wiley eBooks
57. TMX1, a disulfide oxidoreductase, is necessary for T cell function through regulation of CD3ζ
    Timothy Chai, Kyle M. Loh, Irving L. Weissman · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
58. Dual-inactivation of Regnase-1 and SOCS1 rewires exhausted CD8 + T cell fate to enhance anti-tumor functionality
    Isabelle Le Mercier, David Monteiro, Katarina Halpin-Veszeleiova, Karrie Ka Wai Wong, Anne E. Dodson, Gustavo J. Martinez, Dominick A. Matos, Bashar M. Hamza, Ashish Yeri, Seamus McKenney et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
59. Review of T cell proliferation regulatory factors in treatment and prognostic prediction for solid tumors
    Jiayu Li, Shuhan Ma, Hongdi Pei, Jici Jiang, Quan Zou, Zhibin Lv · 2023 · Heliyon
60. CRISPR screens of tumor-infiltrating NK cells identify genetic checkpoints for CAR-NK therapy
    2024 · Nature Biotechnology
61. Construction of a novel CD8T cell-related index for predicting clinical outcomes and immune landscape in ovarian cancer by combined single-cell and RNA-sequencing analysis
    Yu Zhang, Peng Wan, Liangliang Wang, Ruiping Ren · 2025 · Discover Oncology
62. The opportunities and barriers for developing tumour-infiltrating lymphocyte therapy for patients with advanced genitourinary cancers
    Marine Potez, Gabriel Roman Souza, Philippe E. Spiess, Shari Pilon‐Thomas, Jad Chahoud · 2025 · Nature Reviews Urology
63. Large-scale CRISPR-Cas9 screens to define regulators of immune checkpoints
    Michael Mu, Johannes C. Melms, Patricia Ho, Benjamin Izar · 2025 · Methods in cell biology
64. Mitophagy and Immune Infiltration in Primary Sjögren’s Disease: Insights from Bioinformatics Analysis
    Liqiong Hou, Gaxue Jiang, Yanfei Chen · 2026 · International Journal of Molecular Sciences
65. DHX37 protein and mRNA expression patterns in breast and ovarian cancer and their prognostic implications
    Denys Ndeke, Sandra Sam, Nuanphan Polchai, Khalid Alshammari, Megan-Rose Greener, Tangkam R. Marak, Jimmy Joyce, Maisie Henman, Suha Deen, Andrew R. Green et al. · 2026 · Histochemistry and Cell Biology
66. CLASH enables large-scale parallel knock-in for cell engineering
    2023 · Nature Biotechnology
67. CLASH of the Titans: How CAR-T Cells Can Triumph Over Tumors
    Rianne Opstelten, Julian J. Freen‐van Heeren · 2023 · The CRISPR Journal
68. PD-1 Blockage Facilitates Cytotoxic T and NK Cells Tumoricidal Phenotype in a Murine Breast Carcinoma
    Sanja Tripković, Miodrag Jocić, Isidora Stanisavljević, Marina Jovanović, Milena Jurišević, Andjela Petrović, Milan B. Jovanović, Boško Milev, Veljko Marić, Marina Jovanović · 2023 · EABR. Experimental and Applied Biomedical Research
69. A convenient viral transduction based method for advanced multi-engineering of primary human (CAR) T-cells
    Jort J. van der Schans, Afroditi Katsarou, George Kladis, Citlali Bar, Max Medina-Ramírez, Maria Themeli, Tuna Mutis · 2024 · Journal of Genetic Engineering and Biotechnology
70. In vivo T cell CRISPR screens reveal immunotherapeutic targets
    Conor A. Bradley · 2019 · Nature reviews. Cancer
71. Screening for the Next-Generation T Cell Therapies
    Jun Guo, Chenqi Xu · 2020 · Cancer Cell
72. Development and Application of CRISPR-Mediated Genetic Screening in Oncology
    Wanji Li · 2020 · International Conference on Biomedical and Bioinformatics Engineering (ICBBE)
73. Applications of CRISPR-Cas System in Tumor Biology
    Mengdan Ma, Yuchen Liu, Weiren Huang · 2021 · ONCOLOGIE
74. Pooled CRISPR KO Screens for Target Identification
    Antje K. Grotz, Sumit Deswal · 2022 · Wiley eBooks
75. The Cul5 E3 Ligase Complex Is a Key Negative Feedback Regulator of TCR/IL2 Signaling and Anti-Tumor Activity in CD8 + T Cells
    Xiaofeng Liao, Wenxue Li, Ao Li, Barani Kumar Rajendran, Jingjing Ren, Hongyue Zhou, David Calderwood, Benjamin E. Turk, Wenwen Tang, Yansheng Liu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
76. An in vivo CRISPR screen unveils top target genes to improve CAR-T cell efficacy in a solid tumor model
    Mattia Fumagalli, Dongjie An, Luca Simula, Camille Combe, Lisa Aziez, Yannick Simoni, Marie‐Clotilde Alves‐Guerra, Andrea Valentini, Maude Marchais, Anaïs Vermare et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
77. Erasing iatrogenic neoantigens from in vivo CRISPR screens
    Fei Yi, Christopher Austin Klebanoff · 2021 · Immunity
78. Cisplatin Increased the Expression of PD-1 and PD-L1 by YAP1 in Hepatocellular Carcinoma
    Liyuan Hao, Yinglin Guo, Qing Peng, Zhiqin Zhang, Shenghao Li, Jingmin Ji, Yu Xue, Yiwei Liu, Caige Li, Xinli Shi · 2021 · Research Square
79. Advances and application of CRISPR-Cas systems
    Rongming Liu, Liya Liang, Margaret Habib, Emily F. Freed, Carrie A. Eckert · 2022 · Elsevier eBooks
80. Validation‐Based Insertional Mutagenesis (VBIM), A Powerful Forward Genetic Screening Strategy
    Sarmishtha De, Ilaria Tamagno, George Robert Stark, Mark W. Jackson · 2022 · Current Protocols
81. Commercially Available Reagents and Contract Research Services for CRISPR‐Based Studies
    Klio Maratou, Aaron T. Cheng, Fiona M. Behan, Ning Sun, Quinn Lu · 2022 · Wiley eBooks
82. Functional Genomics
    Davide Gianni, Leire Escudero‐Ibarz · 2022 · Wiley eBooks
83. Data from CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
    Dongrui Wang, Briana C. Prager, Ryan C. Gimple, Brenda Aguilar, Darya Alizadeh, Hongzhen Tang, Deguan Lv, Renate Starr, Alfonso Brito, Qiulian Wu et al. · 2023
84. Supplementary Table 2 from CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies
    Dongrui Wang, Briana C. Prager, Ryan C. Gimple, Brenda Aguilar, Darya Alizadeh, Hongzhen Tang, Deguan Lv, Renate Starr, Alfonso Brito, Qiulian Wu et al. · 2023
85. Human effector CD8 + T cells with an exhausted-like phenotype control tumor growth in vivo in a humanized tumor model
    Juliane Mietz, Meike Kaulfuß, Lukas Egli, Lennart Opitz, Christian Münz, Obinna Chijioke · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
86. Research progress on the application of CRISPR/Cas9 technology in breast cancer treatment
    Yuxin Cai · 2023 · Theoretical and Natural Science
87. High-fidelity enhanced AsCas12a knock-in mice for efficient multiplexed gene editing, disease modeling and orthogonal immunogenetics
    Kaiyuan Tang, Xiaoyu Zhou, Shao‐Yu Fang, Erica Vandenbulcke, Andrew Du, Johanna Shen, Hanbing Cao, Jerry Zhou, Krista Chen, Xin Shan et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
88. Stars and Rising Stars in Pediatric Endocrinology: 2022
    2024 · Frontiers research topics
89. Additional file 1 of Strategies to enhance CAR-T persistence
    Yue Liu, Lingna An, Ruihao Huang, Jingkang Xiong, Yang, Haoyu, Xiaoqi Wang, Zhang, Xi · 2022 · Figshare
90. CRISPR screening meets spatial omics: Opportunities and challenges
    Yinxing Ma · 2024 · Elsevier eBooks
91. Altered RNA-processing provides a mechanistic framework delineating human sex-reversal associated with pathogenic variants in the RNA-helicase DHX37
    Maëva Elzaïat, Estelle Talouarn, Somboon Wankanit, Laurène Schlick, Caroline Eozénou, Joëlle Bignon‐Topalovic, Étienne Kornobis, Pierre‐Henri Commère, Chloé Baum, Valérie Seffer et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
92. Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells
    Carli M. Stewart, Claudia Manriquez Roman, Saad S. Kenderian · 2025 · Journal of Visualized Experiments
93. Significance of CD8+T cells related gene ITGB2 in prognosis and tumor microenvironment of small cell lung cancer
    Nana Wang, Wen Tian, Jinhui Zhao, Wenzhong Wang, Fu Mi · 2025 · Medicine
94. Functional Toxicology: Key Concepts and Applications
    Chan Hyeok Kim, Chris D. Vulpe · 2025 · Elsevier eBooks
95. Identification of Target Genes Using Innovative Screening Systems
    Keisuke Sugita, Morito Kurata · 2025 · Pathology International
96. Innovation and Implication of CRISPR-Mediated T-cell Engineering in Cancer Immunotherapy: A New Insight
    Syeda Areej Imran, Hafiz Muhammad Sultan, Muhammad Zubair, Shakira Ghazanfar, Anas Islam, Syed Mustafizur Rahaman, Sumel Ashique · 2025 · Current Cancer Therapy Reviews
97. Live-cell analyses with unsegmented images to study cancer cell response to modified T cell therapy
    Leo Epstein, Adam C. Weiner, Archit Verma, M Saedi, Julia C. Carnevale, Alexander Marson, Barbara Elizabeth Engelhardt · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
98. Recent advances of CRISPR screen in cancer immunology
    Minyi Li, Wanyu Li, Hongshan Guo, Yu Hou · 2025 · Chinese Science Bulletin (Chinese Version)
99. Differences between in vivo and ex vivo models drive divergent perturbation outcomes
    Aarathy Ravi Sundar Jose Geetha, Cynthia del Valle, Wolfgang Esser‐Skala, David Lara‐Astiaso, Nikolaus Fortelny · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
100. Advances in single-cell perturbation modeling
     Xiaoning Qi, Lianhe Zhao, Runsheng Chen, Yi Chen Zhao · 2025 · Chinese Science Bulletin (Chinese Version)